HealthyWay Inc. (HKG:2587)
Hong Kong · Delayed Price · Currency is HKD 1.825
-0.040 (-2.14%)
Aug 21, 2026, 4:08 PM HKT
HealthyWay Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,563 | 1,201 | 1,244 | 569.07 | 431.31 | |
Revenue Growth | 30.13% | -3.51% | 118.68% | 31.94% | - |
Cost of Revenue | 1,086 | 834.86 | 846.22 | 323.27 | 257.83 |
Gross Profit | 476.29 | 365.91 | 398.24 | 245.8 | 173.47 |
Selling, General & Admin | 250.28 | 257.24 | 291.53 | 188.61 | 233.13 |
Research & Development | 169.03 | 96.98 | 103.4 | 54.41 | 14.14 |
Other Operating Expenses | -1.09 | -1.85 | -4.06 | -4.81 | -4.51 |
Operating Expenses | 418.22 | 352.37 | 390.87 | 238.21 | 242.77 |
Operating Income | 58.07 | 13.54 | 7.36 | 7.59 | -69.3 |
Interest Expense | -2.37 | -4.48 | -3.25 | -1.58 | -1.16 |
Interest & Investment Income | 5.58 | 1.12 | 0.68 | 0.19 | 0.55 |
Earnings From Equity Investments | -0.37 | -0.29 | -0.07 | 0.89 | -0.11 |
Currency Exchange Gain (Loss) | -1.5 | -0.93 | -1.25 | -4.84 | 1.46 |
Other Non Operating Income (Expenses) | - | -272.77 | -324.78 | -267.83 | -84.37 |
EBT Excluding Unusual Items | 59.42 | -263.81 | -321.31 | -265.58 | -152.93 |
Gain (Loss) on Sale of Investments | - | - | - | - | 0.29 |
Gain (Loss) on Sale of Assets | -0.37 | 0.01 | 0.36 | 7.98 | 0.56 |
Other Unusual Items | 0.27 | - | - | - | - |
Pretax Income | 59.32 | -263.8 | -320.95 | -257.61 | -152.08 |
Income Tax Expense | 4.98 | 5.36 | -7.06 | -1.97 | 3.22 |
Earnings From Continuing Operations | 54.34 | -269.16 | -313.88 | -255.64 | -155.31 |
Minority Interest in Earnings | 1.34 | 0.7 | 3.8 | -2.49 | -1.92 |
Net Income | 55.68 | -268.46 | -310.08 | -258.13 | -157.22 |
Net Income to Common | 55.68 | -268.46 | -310.08 | -258.13 | -157.22 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 878 | 715 | 700 | - | - |
Shares Outstanding (Diluted) | 878 | 715 | 700 | - | - |
Shares Change | 22.66% | 2.25% | - | - | - |
EPS (Basic) | 0.06 | -0.38 | -0.44 | - | - |
EPS (Diluted) | 0.06 | -0.38 | -0.44 | - | - |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 74.8 | 55.77 | 2.4 | 8.49 | 13.76 |
Free Cash Flow Per Share | 0.09 | 0.08 | 0.00 | - | - |
Gross Margin | 30.48% | 30.47% | 32.00% | 43.19% | 40.22% |
Operating Margin | 3.72% | 1.13% | 0.59% | 1.33% | -16.07% |
Profit Margin | 3.56% | -22.36% | -24.92% | -45.36% | -36.45% |
Free Cash Flow Margin | 4.79% | 4.64% | 0.19% | 1.49% | 3.19% |
EBITDA | 100.73 | 45.34 | 22.27 | 8.22 | -67.65 |
EBITDA Margin | 6.45% | 3.78% | 1.79% | 1.44% | -15.68% |
D&A For EBITDA | 42.66 | 31.8 | 14.91 | 0.64 | 1.65 |
EBIT | 58.07 | 13.54 | 7.36 | 7.59 | -69.3 |
EBIT Margin | 3.72% | 1.13% | 0.59% | 1.33% | -16.07% |
Effective Tax Rate | 8.39% | - | - | - | - |